Home
Paradigm Biocapital Advisors reported a 6.5% stake in Lexeo Therapeutics LXEO · 4,763,198 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 6.5%
- Last report
- 5% · filed 25/11/20
- Shares held
- 4,763,198 sh
- Class
- Common Stock, $0.0001 par value per share
- Event date
- 25/12/31
- Filed
- 26/02/17
6.5% stake · +1.5pp from the last report
- Stake
- 6.5%
- Last report
- 5%
- Since last report
- +1.5pp
Lexeo Therapeutics trades, last 26 weeks
What else happened in Lexeo Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Paradigm Biocapital Advisors's other 5% stake reports
- Paradigm Biocapital Advisors
5% stakeTyra Biosciences
5% stakeTyra Biosciences
TYRA
5.8% stake
3,473,453 sh
5.8% stake
Filed 09/17
- Paradigm Biocapital Advisors
5% stakeAssembly Biosciences
5% stakeAssembly Biosciences
ASMB
7.8% stake
1,553,748 sh
7.8% stake
Filed 08/14
- Paradigm Biocapital Advisors
5% stakeViridian Therapeutics, Inc.\DE
5% stakeViridian Therapeutics, Inc.\DE
VRDN
6.1% stake
6,723,788 sh
6.1% stake
Filed 08/14
- Paradigm Biocapital Advisors
5% stakeLexeo Therapeutics
5% stakeLexeo Therapeutics
LXEO
5.3% stake
4,175,382 sh
5.3% stake
Filed 08/14
- Paradigm Biocapital Advisors
5% stakeEdgewise Therapeutics
5% stakeEdgewise Therapeutics
EWTX
9.5% stake
10,215,455 sh
9.5% stake
Filed 08/14
